Development of Novel Extracellular Vesicle-Based Therapeutic Platforms for Regenerative Medicine
This grant is designed to fund projects that develop new technologies using extracellular vesicles for regenerative medicine. It targets advancements in creating, producing, and utilizing these vesicles as therapeutic solutions.
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)
National Institutes of Health
-
PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
National Institutes of Health
-
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
National Institutes of Health ▸ National Institute of Mental Health
-
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
National Institutes of Health ▸ National Institute of Biomedical Imaging and Bioengineering
-
Collaborations to Enhance Drug Development and Regulatory Science
Food and Drug Administration
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers